Improving the quality of bone tissue regeneration: from bench to bedside via in silico modelling (BRIDGE project)

Tissue engineering is a biomedical engineering field designing and improving man-made living implants to replace diseased or non-functional (parts of) organs. A challenge in tissue engineering is that the complex lab procedures involve a lot of manual work and don’t have clear quality criteria, which is essential for safe clinical applications (1). Consequently, it is very difficult to enlarge these procedures to industrial production levels (2).

Computational models can cope with this complexity and improve the fundamental understanding of the regeneration processes as well as to predict and optimize the patient-specific treatment strategies (3).

The BRIDGE project focusses on bone tissue engineering. State-of-the-art biomimetic processes based on in silico models increase the quantity and quality of the in vivo outcome of the tissue engineering manufacturing process. Moreover, the project aims at understanding and control to the quality of the production process. These factors are important for patient safety ultimately.

In silico models of four key elements (cells, carriers, culture and clinics) are already used in orthopaedics for the planning of complicated surgeries, personalised implant design and the analysis of gait measurements (4).

In one of the studies of the BRIDGE project (5), the critical role of oxygen is examined in bone fracture healing, using a multiscale model that is compared with previous experimental and in silico results. The oxygen model was also applied to a challenging clinical case where it predicted the healing perspectives.

This BRIDGE study demonstrates that in silico models are a powerful tool to further unravel the complex spatiotemporal interplay during the bone repair process, which is a crucial step in the development of safer implants.

(1) Geris L. Model-guided bone tissue engineering: from bench to bedside via in silico modelling (conference abstract). Virtual Physiological Human Conference 2014
(2) Geris L. Biomimetic process design for tissue regeneration: from bench to bedside via in silico modelling. Grant ERC-2011-StG, panel PE8, Biomechanics Research Unit, University of Liège, Liège, Belgium & Prometheus, Division of Skeletal Tissue Engineering Leuven, KU Leuven, Leuven, Belgium & Biomechanics Section, KU Leuven, Leuven, Belgium (http://www.kuleuven.be/research/excellence/medical_technologies/geris.html and http://cordis.europa.eu/project/rcn/101422_en.html, accessed on 9 June 2016)
(3) Carlier A, Geris L, Lammens J, Van Oosterwyck H. Bringing computational models of bone regeneration to the clinic. Wiley interdisciplinary reviews. Systems biology and medicine 2015, Vol 7 (4), P 183-194, DOI 10.1002/wsbm.1299
(4) Geris L. Regenerative orthopaedics: in vitro, in vivo … in silico. International Orthopaedics (special issue on regenerative orthopaedics) 2014, Vol 38 (9), P 1771-1778
(5) Carlier A, Geris L, Van Gastel N, Carmeliet G, Van Oosterwyck H. Oxygen as a critical determinant of bone fracture healing-a multiscale model. Journal of Theoretical Biology 2015, Vol 365, P 247-264

Avicenna Alliance news

THE ROLE OF ARTIFICIAL INTELLIGENCE WITHIN IN SILICO MEDICINE

A range of authors across academia and industry, representing both the Avicenna Alliance and the Virtual Physiological Human Institute,...

find out more ›

Toward a regulatory pathway for Using in Silico Trials in CE Marking of Medical Devices

 

A team of researchers of the In Silico World project, including several key Avicenna Alliance members, led...

find out more ›

Avicenna Alliance response to the ICHE11A Consultation

The Avicenna Alliance strongly supports and welcomes the ICH’s proposed goal of harmonizing methods and strategies for improved paediatric drug...

find out more ›

Avicenna Alliance Feedback to the European Health Data Space Call for Feedback

The Avicenna Alliance welcomes the proposal for the EHDS. The Alliance is a multistakeholder group with the mission of...

find out more ›

We are honored to welcome Zimmer Biomet as a new Avicenna’s member!

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve...

find out more ›

Avicenna Alliance Response to 2023 Stakeholders' Targeted Consultation on EU4Health

The Avicenna Alliance stressed the need for further support and guidance for digital evidence from in silico...

find out more ›

New Avicenna APAC Task Force

A new Task Force joined the International Affairs Working Group!

find out more ›

Cécile De Coster is the new Avicenna Pharmaceutical Strategy Task Force Co-chair

We are proud to welcome Cécile De Coster as the new Avicenna Pharmaceutical Strategy Task Force co-chair!

find out more ›

Avicenna Alliance goes on growing by welcoming Edwards Lifesciences as a new member!

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and...

find out more ›

Avicenna Alliance is honoured to welcome Alfasigma as a new member!

Privately owned, Alfasigma is one of the leading Italian pharmaceutical companies, present in over 90 countries, through...

find out more ›

EU-funded project successfully develops AI software that grows and treats cancerous tumors 

The Horizon Europe 2020 project EVO-NANO (Evolvable platform for programmable nanoparticle-based cancer...

find out more ›

In silico used to validate Omicron variant detection method! 

The Joint Research Centre (JRC) has developed a new method to detect the Omicron variant of COVID-19, which differs in its nucleic acid...

find out more ›

The priorities of the upcoming French Presidency of the Council of the European Union - what’s new for Avicenna? 

The French Presidency of the Council of the European Union is due to start on 1...

find out more ›

New Avicenna UK Insilico Regulatory Innovation Task Force

The Avicenna International Affairs Working Group adds a new task force to its structure.

find out more ›

In Silico in Innovation – again!

The European Innovation Council (EIC) has released its second wave of “start-up champions” to receive funding for innovations through the EIC Accelerator. The EIC...

find out more ›

Avicenna Alliance meets with MEPs to discuss in silico medicine

On 7 October, Dr. Liesbet Geris (Research Professor in Biomechanics and Computational Tissue Engineering at the Universities of Liège &...

find out more ›

The Joint Research Centre advocates for a “paradigm change” to in silico research methods!

For the second week in a row, the Joint Research Centre (JRC) – part of the European Commission’s EU Science...

find out more ›

The European Commission Joint Research Centre publishes a public knowledge base of non-animal models used in immuno-oncology

The Joint Research Centre (JRC), which is part of the European...

find out more ›

The State of the (European) Union

On 15 September, Commission President Ursula von der Leyen delivered her second State of the Union speech at the European Parliament in Strasbourg. She took stock of...

find out more ›

The BECA Beat 

The European Parliament’s Special Committee on Beating Cancer (BECA) met for the first time in September of 2020. BECA was established to create actionable recommendations for Member...

find out more ›

Avicenna Alliance prepares for the next EU policy session 

As September begins, politicians have returned to their EU posts and are preparing for what will be a busy few months for health policy. The...

find out more ›

Joint Research Centre of the Commission launches report on national strategies for Artificial Intelligence!

The Joint Research Centre of the European Commission (JRC) recently published a new report...

find out more ›

Conference of the Slovenian Council Presidency addresses digital twin technologies and digitalisation in healthcare!

On 15 and 16 July, the Slovenian Presidency of the Council of the European Union ...

find out more ›

WHO issues first global report on use of AI in healthcare

Artificial Intelligence (AI) applications in health innovation are rapidly increasing, reflecting the potential of these technologies to...

find out more ›

Slovenian Presidency of the Council of the EU launches its six-month programme!

On 1 July, for the second time since joining the EU in 2004, Slovenia has taken over the Presidency of the Council of...

find out more ›

Members of the European Parliament call EU Health Commissioner to place in silico medicine on her policy agenda from 2021 onwards!

On 22 June, a group of five Members of the European Parliament...

find out more ›

Our new position paper on in silico evidence in the regulatory approval of medical devices is out!

The Avicenna Alliance is proud to announce the recent publication of its new position paper...

find out more ›

Happy 5th Anniversary to the Avicenna Alliance!  

5 years ago, based on the very enlightening Avicenna Roadmap Project Report, the Avicenna Alliance was established at the suggestion of European...

find out more ›

EU New Medical Device Regulation now in force! In silico mentioned for the first time

After a one-year postponement following the COVID-19 pandemic, the European Commission’s Medical Devices...

find out more ›

The European Commission adopts Communication on Europe's global approach to cooperation in research and innovation

On 18 May, the European Commission adopted a Communication on its global approach...

find out more ›

Avicenna Alliance provides feedback on the European Commissions’ roadmap for the revision of the EU general pharmaceuticals legislation

On 27 April, the Avicenna Alliance has submitted its feedback...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up